(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 9.22% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 21.71%.
Rockwell Medical's revenue in 2026 is $67,680,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $291,760,511, with the lowest RMTI revenue forecast at $280,250,971, and the highest RMTI revenue forecast at $300,412,400.
In 2027, RMTI is forecast to generate $315,257,180 in revenue, with the lowest revenue forecast at $294,405,021 and the highest revenue forecast at $333,622,711.